[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (4R,4aR,5R,6aR,6aS,6bR,8R,8aR,9R,10R,11S,12aR,14bR)-5,8,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4-carboxylate

Details

Top
Internal ID 36964f00-ddeb-478e-af5f-576380221e87
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids
IUPAC Name [(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (4R,4aR,5R,6aR,6aS,6bR,8R,8aR,9R,10R,11S,12aR,14bR)-5,8,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4-carboxylate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(COC2OC(=O)C3CC(CC4C3C(CC5(C4=CCC6C5(CC(C7C6(CC(C(C7(C)CO)OC8C(C(C(C(O8)CO)O)O)O)O)C)O)C)C)O)(C)C)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2OC(=O)[C@@H]3CC(C[C@@H]4[C@H]3[C@@H](C[C@@]5(C4=CC[C@H]6[C@]5(C[C@H]([C@@H]7[C@@]6(C[C@@H]([C@@H]([C@@]7(C)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)O)C)C)O)(C)C)O)O)O)O)O
InChI InChI=1S/C47H76O20/c1-18-29(54)32(57)34(59)40(63-18)65-36-30(55)25(53)16-62-42(36)67-39(61)20-11-43(2,3)10-19-21-8-9-27-44(4)12-24(52)38(66-41-35(60)33(58)31(56)26(15-48)64-41)45(5,17-49)37(44)23(51)14-47(27,7)46(21,6)13-22(50)28(19)20/h8,18-20,22-38,40-42,48-60H,9-17H2,1-7H3/t18-,19-,20+,22+,23+,24-,25-,26+,27+,28+,29-,30-,31+,32+,33-,34+,35+,36+,37+,38-,40-,41-,42-,44+,45-,46+,47+/m0/s1
InChI Key YZSHNISTCVUURM-SDMNTLTGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C47H76O20
Molecular Weight 961.10 g/mol
Exact Mass 960.49299481 g/mol
Topological Polar Surface Area (TPSA) 335.00 Ų
XlogP -1.70
Atomic LogP (AlogP) -2.45
H-Bond Acceptor 20
H-Bond Donor 13
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (4R,4aR,5R,6aR,6aS,6bR,8R,8aR,9R,10R,11S,12aR,14bR)-5,8,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,4a,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8141 81.41%
Caco-2 - 0.8908 89.08%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.8571 85.71%
Subcellular localzation Mitochondria 0.8084 80.84%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8118 81.18%
OATP1B3 inhibitior - 0.3556 35.56%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.8755 87.55%
P-glycoprotein inhibitior + 0.7477 74.77%
P-glycoprotein substrate + 0.6147 61.47%
CYP3A4 substrate + 0.7211 72.11%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8774 87.74%
CYP3A4 inhibition - 0.9322 93.22%
CYP2C9 inhibition - 0.8970 89.70%
CYP2C19 inhibition - 0.9028 90.28%
CYP2D6 inhibition - 0.9383 93.83%
CYP1A2 inhibition - 0.8916 89.16%
CYP2C8 inhibition + 0.7013 70.13%
CYP inhibitory promiscuity - 0.9600 96.00%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.6356 63.56%
Eye corrosion - 0.9897 98.97%
Eye irritation - 0.9056 90.56%
Skin irritation - 0.6683 66.83%
Skin corrosion - 0.9490 94.90%
Ames mutagenesis - 0.6454 64.54%
Human Ether-a-go-go-Related Gene inhibition + 0.6647 66.47%
Micronuclear - 0.8200 82.00%
Hepatotoxicity - 0.7552 75.52%
skin sensitisation - 0.8695 86.95%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity - 0.6750 67.50%
Nephrotoxicity - 0.7758 77.58%
Acute Oral Toxicity (c) III 0.7393 73.93%
Estrogen receptor binding + 0.8207 82.07%
Androgen receptor binding + 0.7299 72.99%
Thyroid receptor binding - 0.5125 51.25%
Glucocorticoid receptor binding + 0.7403 74.03%
Aromatase binding + 0.6410 64.10%
PPAR gamma + 0.8010 80.10%
Honey bee toxicity - 0.6548 65.48%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.6150 61.50%
Fish aquatic toxicity + 0.9590 95.90%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.15% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.46% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.40% 96.09%
CHEMBL3714130 P46095 G-protein coupled receptor 6 95.18% 97.36%
CHEMBL2581 P07339 Cathepsin D 92.00% 98.95%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 90.95% 96.77%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.69% 97.09%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 89.63% 86.92%
CHEMBL226 P30542 Adenosine A1 receptor 88.80% 95.93%
CHEMBL218 P21554 Cannabinoid CB1 receptor 88.63% 96.61%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.76% 86.33%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.58% 94.00%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 86.27% 96.21%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.95% 95.56%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.86% 100.00%
CHEMBL4208 P20618 Proteasome component C5 82.07% 90.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.89% 94.45%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Mimusops elengi

Cross-Links

Top
PubChem 162969849
LOTUS LTS0210444
wikiData Q105369439